TotalSeq™-B0943 anti-human GM-CSF Antibody, GM-CSF, BVD2-21C11,BioLegend,502321

Additional reported applications (for the relevant formats) include: ELISA1-4or ELISPOT3,4Detection, Neutralization1, immunohistochemical staining of paraformaldehyde-fixed, saponin-treated5,6and acetone-fixed7frozen tissue sections, and immunocytochemistry.Note:For testing human GM-CSF in serum or plasma, BioLegend's ELISA Max™ Sets (Cat. No. 432001 to 432006) are specially developed and recommended.

Host

Rat

Reactivity

Human

Application

ICPG - Quality tested

Platform ID

BAB212409932

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameTotalSeq™-B0943 anti-human GM-CSF Antibody, GM-CSF, BVD2-21C11
Cat. No.502321
HostRat
RRIDAB_3097227 (BioLegend Cat. No. 502321)
IsotypeRat IgG2a, κ
ReactivityHuman
ApplicationICPG - Quality tested
ClonalityMonoclonal
Clone NumberBVD2-21C11
Concentration0.5 mg/mL
TargetGM-CSF
ImmunogenE. coli-expressed, recombinant human GM-CSF.
PurityThe antibody was purified by chromatography and conjugated with TotalSeq™-B oligomer under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

Granulocyte/macrophage - colony stimulating factor (GM-CSF) is a hematopoietic factor that is produced by activated T cells, B cells, mast cells, macrophages, fibroblasts, and endothelial cells. In addition to supporting colony formation of granulocyte/macrophage progenitors, GM-CSF is a growth factor for erythroid, megakaryocyte, and eosinophil progenitors.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.